LIVER CANCER-PART I
WEBINAR:
FEB 15, 2024
5:30pm to 6:30pm PDT
Liver cancer remains a global health challenge. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for about 90% of cases. With approximately 906,000 new cases and 830,000 deaths in 2020 worldwide, primary liver cancer was the seventh most diagnosed cancer and the second leading cause of cancer death. Hepatocellular carcinoma (HCC, representing 75–85% of cases) and intrahepatic cholangiocarcinoma (ICC, a rare form of cancer that occurs in the parts of the bile ducts that are within the liver, representing about 10% ) are two of the most common primary liver cancer.
Please join us on February 15th to learn more about liver cancer, its causes, the new early-detection diagnostic tools and treatments.
WHAT IS HEPATORENAL SYNDROME (HRS)?
WEBINAR:
Feb 29, 2024
5:30pm to 6:30pm PDT
Hepatorenal Syndrome is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis, ascites, portal hypertension, or sudden liver failure. HRS may be fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent advancement of the condition. The only certain way to prevent HRS is to keep your liver healthy.
To reduce your risk of developing cirrhosis, avoid drinking excessive amounts of alcohol, and avoid contracting Hepatitis. To learn more register to attend our free webinar on HRS
DRUGS, ALCOHOL & ALCOHOL-ASSOCIATED HEPATITIS
WEBINAR:
APRIL 17, 2024
5:30pm to 6:30pm PDT
Your liver breaks down most of the alcohol you drink so that it can be removed from the body. This process creates substances that are harmful to your body and the liver itself. Large amounts of these substances can damage liver cells and cause serious liver disease.
Chronic and excessive alcohol consumption produces a wide spectrum of hepatic lesions, the most characteristic of which are steatosis, hepatitis, and fibrosis/cirrhosis. Steatosis is the earliest response to heavy drinking and is characterized by the deposition of fat in hepatocytes. Steatosis can progress to steatohepatitis, which is a more severe, inflammatory type of liver injury, and culminate in alcoholic cirrhosis, which is the most advanced and irreversible form of liver injury related to the consumption of alcohol.
To learn more about Alcoholic Hepatitis (AH) we invite you to join us for a lively presentation and round table on the subject.
VIRAL HEPATITIS
WEBINAR:
MAY 16, 2024
5:30pm to 6:30pm PDT
Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, chemicals, drugs, toxins, some medications, and certain medical conditions can cause hepatitis.
There are five main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of the illness, and prevention methods.
In this webinar our expert hepatologists will share with you the most current information about viral hepatitis and will respond to your questions.
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC)
WEBINAR:
MAY 30, 2024
5:30pm to 6:30pm PDT
During the 2024 year we are dedicating several webinars to rare diseases among children and adults. This webinar is on Progressive Familial Intrahepatic Cholestasis, or PFIC, which represents a group of rare genetic disorders that cause progressive liver disease and can lead to fibrosis, cirrhosis, and end-stage liver disease. One of the symptoms of PFIC is the insatiable itching of the skin. The pruritus, or itching, may become so severe to cause skin mutilation, loss of sleep, irritability, poor attention, and impaired performance. PFIC1, PFIC2 and PFIC3 are the most common variations of PFIC. In addition, other rare forms of PFIC exist with varying phenotypes, but all present with cholestasis.
In this webinar our expert presenter will provide updated and accurate information about PFIC, symptoms, and available treatments. while responding to your questions.
Global Fatty Liver Day
MASLD and MASH
WEBINAR:
JUN 13, 2024
5:30pm to 6:30pm PDT
June 13th is the Global Fatty Liver Day. This webinar will help you understand Fatty Liver Disease and its new names MASLD or Metabolic dysfunction-associated Steatotic Liver Disease, also known as Non-alcoholic Fatty Liver Disease (NAFLD).
Fatty Liver Disease is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. The main characteristic of MASLD (NAFLD) is the buildup of extra fat in liver cells. MASLD is increasingly common around the world, affecting about one-quarter of the population.
Mash (Also known as NASH) is the metabolic Dysfunction-associated Steatohepatitis is the most sever form of MASLD. We invite you to join this educational webinar and learn how to protect your liver and your life. Our expert hepatologists will respond to your questions.
WILSON DISEASE
WEBINAR:
JUN 20, 2024
5:30pm to 6:30pm PDT
Wilson disease is an inherited disorder that causes copper to build up in the liver, brain, and other organs. While copper plays a vital role in the health development of nerves and bones, too much coper is toxic. Most people with the condition are born with it, but symptoms often don't appear until later in life.
Symptoms are typically related to the brain and liver. Liver-related symptoms include vomiting, weakness, fluid build-up in the abdomen, swelling of the legs, yellow skin and itchiness. Brain-related symptoms include tremors, muscle stiffness, trouble in speaking, personality changes, anxiety, and psychosis.
To learn more about this complicated rare disease please register to join us:
CIRRHOSIS
WEBINAR:
JUL 18, 2024
5:30pm to 6:30pm PDT
Cirrhosis is a condition in which your liver is scarred and permanently damaged. Scar tissue replaces healthy liver tissue and prevents your liver from working normally. As cirrhosis gets worse, your liver begins to fail. Cirrhosis has many signs and symptoms, such as fatigue and severe itchy skin. Symptoms may not appear until the liver is badly damaged.
Cirrhosis is most often the end result of chronic liver damage caused by long-term liver disease. Common causes of chronic liver disease in the United States are Hepatitis B or Hepatitis C infection, alcohol abuse, buildup of fat in the liver cells that is not created by drinking too much alcohol (known as MASLD or NAFLD) and MASH (also known as NASH). Cirrhosis is closely related to being overweight, having high blood pressure, diabetes or pre-diabetes, and high cholesterol level.
In this webinar our experts will define and explain Cirrhosis, the most current medical news and treatments about cirrhosis, and will respond to your question.
RARE LIVER DISEASE
PRIMARY BILIARY CHOLANGITIS
WEBINAR:
AUG 22, 2024
5:30pm to 6:30pm PDT
Primary Biliary Cholangitis (PBC) is an autoimmune disease in which the bile ducts are inflamed and slowly destroyed. It previously was called primary biliary cirrhosis.
Bile is a fluid made in the liver. It helps with digestion and absorbing certain vitamins. It also helps the body absorb fats and get rid of cholesterol, toxins, and worn-out red blood cells. Ongoing inflammation in the liver can lead to bile duct inflammation and damage known as cholangitis. At times, this can lead to permanent scarring of liver tissue, called cirrhosis. It also can eventually lead to liver cancer and liver failure.
Although it affects both sexes, primary biliary cholangitis mostly affects women. It's considered an autoimmune disease, which means your body's immune system is mistakenly attacking healthy cells and tissue. Researchers think a combination of genetic and environmental factors triggers the disease. It usually develops slowly.
Learn about PBC, its causes, symptoms, and the most current treatments in this free webinar, where expert hepatologists will offer the latest information and will respond to your questions.
.jpg)
LIVER CANCER-PART II
WEBINAR:
SEP 12, 2024
5:30pm to 6:30pm PDT
The development of liver cancer (HCC) is attributed to fibrosis, and cirrhosis, which occur in the setting of chronic liver injury and inflammation, closely linked to chronic viral Hepatitis infection (Hep B and C), or exposure to toxins. Certain diseases such as MASLD or Metabolic dysfunction-associated Steatotic Liver Disease, also known as Non-alcoholic Fatty Liver Disease (NAFLD), and Metabolic Dysfunction-associated Steatohepatitis, or MASH (Also known as NASH) are also increasingly recognized as causes of liver cancer. In the U.S., about 25% of the adult population has metabolic syndrome, a proportion increasing with age, particularly among racial and ethnic minorities. However, in recent years the increase of obesity in young adults and children has raised more concern about liver cancer.
In this webinar expert hepatologists will discuss the reasons for the rise of liver cancer death, the relations between liver cancer and hepatitis, and will review MASLD and MASH’s connection with liver cancer. Please join us.
AUTOIMMUNE HEPATITIS
WEBINAR:
SEP 26, 2024
5:30pm to 6:30pm PDT
In this webinar we will learn about autoimmune hepatitis.
Autoimmune hepatitis is liver inflammation that occurs when your body's immune system turns against liver cells. The exact cause of autoimmune hepatitis is unclear, but genetic and environmental factors appear to interact over time in triggering the disease. When diagnosed and treated early autoimmune hepatitis often can be controlled with drugs that suppress the immune system.
Doctors have identified two main forms of autoimmune hepatitis. Type 1 autoimmune hepatitis. This is the most common type of disease. It can occur at any age. Type 2 autoimmune hepatitis. Although adults can develop type 2 autoimmune hepatitis, it's most common in children and young people.
Alagille syndrome (ALGS) is a rare genetic disorder that can affect multiple organ systems of the body including the liver, heart, skeleton, eyes, and kidneys. Common symptoms, which often develop during the first three months of life, include blockage of the flow of bile from the liver, yellowing of the skin and mucous membranes (jaundice), poor weight gain and growth, and severe itching (pruritis).
As treatment options increase, people with this condition live longer, more comfortable lives, especially if the condition is discovered early.
Please join our experts hepatologists to learn more and have your questions answered.
RARE LIVER DISEASE
BILIARY ATRESIA
WEBINAR:
OCT 29, 2024
5:30pm to 6:30pm PDT
Biliary Atresia is a rare liver disease that occurs in infants. In this condition the bile ducts outside and inside the liver are scarred and blocked. Bile can’t flow into the intestine, so bile builds up in the liver and damages it. The damage leads to scarring, loss of liver tissue and function, and cirrhosis.
Biliary atresia is often found shortly after birth. Jaundice (yellowing of the skin) and pale stools that start in the first 4-8 weeks of life are the main signs of the disease.
The causes of biliary atresia are not completely understood. For some children, biliary atresia may occur because the bile ducts did not form properly during pregnancy. For other children with biliary atresia, the bile ducts may be damaged by the body's immune system because of a viral infection that happened after birth.
In this webinar our experts will explain Biliary Atresia, its causes, treatments, and will respond to your questions. The family of a Biliary Atresia patient who received liver transplant will share their story with us as well.
What Is Alagille Syndrome
(ALGS)
WEBINAR:
DEC 19, 2024
5:30pm to 6:30pm PDT
Alagille syndrome (ALGS) is a condition affecting the liver, heart, spine, eye, face, kidneys, and blood vessels that is caused by changes (mutations) in a gene called "JAGGED1.” ALGS is a rare condition. Most patients with ALGS have liver disease caused by "bile duct paucity," which means a decrease in the number of bile ducts in the liver. It is now recognized that ALGS is caused by abnormal development of many organs. In some patients, the heart problems caused by ALGS are much more important than liver disease.
Infants with ALGS may show jaundice (a yellowish tinge in the eyes and skin), pale or loose stools, poor growth, and may have problems breathing or have pale or dusky skin color (if a heart problem is serious). Most patients with ALGS show signs and symptoms of liver problems at birth or soon after.
To learn more, please join us for this free webinar where our experts will discuss this disease and review the latest in ALGS treatments.
MASLD/MASH
WEBINAR:
TBD
5:30pm to 6:30pm PDT
MASLD or Metabolic dysfunction-associated Steatotic Liver Disease, also known as Non-alcoholic Fatty Liver Disease (NAFLD), is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. The main characteristic of MASLD (NAFLD) is the buildup of extra fat in liver cells.
MASLD is increasingly common around the world and is the most common form of chronic liver disease, affecting about one-quarter of the population.
MASH (Also known as NASH) is the metabolic Dysfunction-associated Steatohepatitis is the most sever form of MASLD. We invite you to join this educational webinar and learn how to protect your liver and your life.
LIVER CANCER-PART III
WEBINAR:
TBD
5:30pm to 6:30pm PDT
In this final Liver cancer webinar, our expert hepatologists and surgeons will offer more vital information about Hepatocellular carcinoma (the most common type of liver cancer) as well as other cancers related to liver. Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach, and performs over 500 lifesaving tasks to keep you safe and healthy.
Several types of cancer can form in the liver. The most common type of liver cancer is hepatocellular carcinoma (HCC), which begins in the main type of liver cell (hepatocyte). Other types of liver cancer, such as intrahepatic cholangiocarcinoma (Cancer that occurs in the parts of the bile ducts that are within the liver) and hepatoblastoma (a rare type of liver cancer that usually affects children under the age of 3), are much less common. Cancer that spreads to the liver is more common than cancer that begins in the liver cells.
Please join us. Our experts will respond to your questions at the webinar.
TRANSPLANT & ORGAN DONATION
WEBINAR:
TBD, 2024
5:30pm to 6:30pm PDT
Liver transplantation or hepatic transplantation is the replacement of a diseased liver with a healthy liver from another person. Liver transplantation is a treatment option for end-stage liver disease and acute liver failure. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver.
The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians and supporting medical teams.
The availability of donated organs is a major limitation. The idea of donating organs still seems to be foreign to many of us, even in cases of giving the gift of life through living organ donation. At any given time, there are over 100,000 people who are waiting and hoping to receive a donated organ. Organ donation can and does save lives.
In this webinar we will learn about liver transplantation and will receive information about organ and tissue donation and the meticulous process of procuring a donated organ. Please join us.